Barda procures regeneron's regn-eb3 investigational ebola treatment for national preparedness

Tarrytown, n.y., july 29, 2020 /prnewswire/ -- regn-eb3 is a novel anti-viral antibody cocktail developed using the same rapid response technologies as regn-cov2, regeneron's investigational covid-19 antibody cocktail regeneron pharmaceuticals, inc.
REGN Ratings Summary
REGN Quant Ranking